It’s that time of year again when scientists, researchers, clinicians, and students gather to discuss the latest scientific advances in tropical medicine, hygiene, and global health at the American Society ...
Read more
Tag: research
TCV remains immunogenic for at least two years among Bangladeshi children
Typhoid remains a major public health issue in many parts of the world. In Bangladesh, more than 1,100 cases of typhoid per 100,000 people occur each year, which is one ...
Read more
Prioritizing TCV introduction in Africa: Time for decision-makers to act with urgency
As another year draws to a close, policymakers, researchers, and partners are convening in South Africa to discuss typhoid, TCV, and the work that remains to combat this disease. Despite ...
Read more
Typhoid takes a spotlight during the 2022 VASE Conference
VASE expands its scope Hundreds of scientists, public health professionals, immunization leaders, vaccine industry representatives, international donors, and other global experts gathered in Washington D.C. for the 2022 Vaccines Against ...
Read more
Test-negative design proves to be suitable for typhoid vaccine effectiveness evaluations
Background on test-negative design Typhoid continues to be a public health threat in sub-Saharan Africa. However, typhoid conjugate vaccine (TCV) is a proven intervention to reduce the burden of typhoid ...
Read more
Taking on Typhoid at ASTMH: A vital forum for global health collaboration and exchange
Each year, the American Society for Tropical Medicine and Hygiene (ASTMH) annual meeting brings together scientists and researchers from around the world to share the latest data on tropical medicine ...
Read more
Why TCV now? Why not? Reflections from the Asia Regional Meeting on Typhoid & TCV
Last week stakeholders from 15 countries in the Asia and Western Pacific region gathered in a first of its kind meeting to discuss typhoid and typhoid conjugate vaccines (TCV). Decision-makers ...
Read more
New TCV data from Malawi highlight longer-term immune response
Typhoid conjugate vaccine (TCV) is highly immunogenic in Malawian children as young as 9 months of age! New data show TCV elicits a strong immune response among both young children ...
Read more
Confirmed! TCV can be co-administered with routine measles-rubella AND yellow fever vaccines at 9 months
To read this blog in French, please click here. Newly published data from Groupe de Recherche Action en Santé (GRAS), Burkina Faso found typhoid conjugate vaccine (TCV) is safe and ...
Read more
Strike while the iron is hot
The Sabin Vaccine Institute will broadcast the Gold Medal Ceremony live on June 3, 2021 at 3 PM EST. Register here. The Sabin Vaccine Institute’s 2021 Rising Star recipient, Dr. ...
Read more
